From Evestra Signs Deal with Glemark for Generic Version of NuvaRing:

Circular—

Stock image from Unsplash user Julian Bock. Used in accordance with Unsplash creative commons license https://unsplash.com/license https://unsplash.com/search/circular-ring?photo=Y6-GL40aPPs

Underwriters and Partners

Xconomy Insight

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

From Our Editors · Podcast
Xcelerating Life Sciences Philadelphia: The Highlights Podcast
Becoming the Cell & Gene Therapy Hub

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy Boston

Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4

FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats

Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

“Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D

Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More

Neogene Therapeutics Grabs $110M to Tackle Solid Tumors With Cell Therapy

Xcelerating Life Sciences New York

From Evestra Signs Deal with Glemark for Generic Version of NuvaRing:

Underwriters and Partners

Robert Langer reveals secrets to early-stage biotech success

What’s Next in Neuroscience Therapies

Xcelerating Life Sciences Philadelphia: The Highlights Podcast

Xconomy on Demand

We offer a number of ways to subscribe for free!